Login / Register
Menu
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
Search
×
Cancer Tissue Gallery HMGA2
Path
Created with Sketch.
Go to HMGA2 Normal Tissue Gallery
Go back to Product Page
Adrenal gland – Adrenocortical carcinoma with a weak HMGA2 staining of most tumor cells
Adrenal gland – Adrenocortical carcinoma with a weak HMGA2 staining of most tumor cells
Adrenal gland – HMGA2 negative pheochromocytoma
Adrenal gland – HMGA2 negative pheochromocytoma
Anal canal – Squamous cell carcinoma with strong HMGA2 staining of tumor cells
Anal canal – Squamous cell carcinoma with strong HMGA2 staining of tumor cells
Breast – HMGA2 negative invasive breast cancer of no special type (NST)
Breast – HMGA2 negative invasive breast cancer of no special type (NST)
Breast – HMGA2 negative invasive lobular breast cancer
Breast – HMGA2 negative invasive lobular breast cancer
Colon – Colorectal adenocarcinoma showing a faint HMGA2 positivity a small set of tumor cells
Colon – Colorectal adenocarcinoma showing a faint HMGA2 positivity a small set of tumor cells
Colon – Colorectal adenocarcinoma with strong HMGA2 staining of tumor cells
Colon – Colorectal adenocarcinoma with strong HMGA2 staining of tumor cells
Colon – Colorectal adenoma (low-grade) with weak to moderate HMGA2 staining of neoplastic cells
Colon – Colorectal adenoma (low-grade) with weak to moderate HMGA2 staining of neoplastic cells
Esophagus – Adenocarcinoma with strong HMGA2 positivity of tumor cells
Esophagus – Adenocarcinoma with strong HMGA2 positivity of tumor cells
Esophagus – HMGA2 negative squamous cell carcinoma
Esophagus – HMGA2 negative squamous cell carcinoma
Esophagus – Squamous cell carcinoma with strong HMGA2 staining of tumor cells
Esophagus – Squamous cell carcinoma with strong HMGA2 staining of tumor cells
Kidney – HMGA2 negative clear cell carcinoma
Kidney – HMGA2 negative clear cell carcinoma
Kidney – Papillary renal cell carcinoma with strong HMGA2 immunostaining of all tumor cells
Kidney – Papillary renal cell carcinoma with strong HMGA2 immunostaining of all tumor cells
Liver – Cholangiocellular carcinoma with strong HMGA2 positivity of tumor cells
Liver – Cholangiocellular carcinoma with strong HMGA2 positivity of tumor cells
Liver – Hepatocellular carcinoma with exhibiting a strong HMGA2 staining of tumor cells
Liver – Hepatocellular carcinoma with exhibiting a strong HMGA2 staining of tumor cells
Liver – HMGA2 negative cholangiocellular carcinoma
Liver – HMGA2 negative cholangiocellular carcinoma
Lung – Adenocarcinoma with strong HMGA2 staining of all tumor cells
Lung – Adenocarcinoma with strong HMGA2 staining of all tumor cells
Lung – HMGA2 negative malignant mesothelioma
Lung – HMGA2 negative malignant mesothelioma
Lung – Malignant mesothelioma with strong HMGA2 immunostaining of tumor cells
Lung – Malignant mesothelioma with strong HMGA2 immunostaining of tumor cells
Lung – Squamous cell carcinoma with a variable (weak – strong) HMGA2 staining of tumor cells
Lung – Squamous cell carcinoma with a variable (weak – strong) HMGA2 staining of tumor cells
Lymph node – HMGA2 negative B-CLL
Lymph node – HMGA2 negative B-CLL
Lymph node – HMGA2 negative diffuse large B-cell lymphoma
Lymph node – HMGA2 negative diffuse large B-cell lymphoma
Lymph node – HMGA2 negative Hodgkin’s lymphoma
Lymph node – HMGA2 negative Hodgkin’s lymphoma
Lymph node – Hodgkin’s lymphoma exhibiting a strong HMGA2 staining of tumor cells
Lymph node – Hodgkin’s lymphoma exhibiting a strong HMGA2 staining of tumor cells
Lymph node – Hodgkin’s lymphoma showing a strong HMGA2 staining of tumor cells
Lymph node – Hodgkin’s lymphoma showing a strong HMGA2 staining of tumor cells
Lymph node – Hodgkin’s lymphoma with strong HMGA2 immunostaining of tumor cells
Lymph node – Hodgkin’s lymphoma with strong HMGA2 immunostaining of tumor cells
Oral cavity – Squamous cell carcinoma with strong HMGA2 staining of tumor cells
Oral cavity – Squamous cell carcinoma with strong HMGA2 staining of tumor cells
Ovary – Granulosa cell tumor with a moderate intensity HMGA2 staining of tumor cells
Ovary – Granulosa cell tumor with a moderate intensity HMGA2 staining of tumor cells
Ovary – HMGA2 negative serous high-grade carcinoma
Ovary – HMGA2 negative serous high-grade carcinoma
Ovary – Malignant mixed Mullerian tumor with strong HMGA2 staining of all epithelial and mesenchymal tumor cells
Ovary – Malignant mixed Mullerian tumor with strong HMGA2 staining of all epithelial and mesenchymal tumor cells
Ovary – Serous high-grade carcinoma with a variable (weak – strong) HMGA2 staining of tumor cells
Ovary – Serous high-grade carcinoma with a variable (weak – strong) HMGA2 staining of tumor cells
Ovary – Serous high-grade carcinoma with strong HMGA2 staining of all tumor cells
Ovary – Serous high-grade carcinoma with strong HMGA2 staining of all tumor cells
Pancreas – Ductal adenocarcinoma with moderate intensity HMGA2 staining of tumor cells
Pancreas – Ductal adenocarcinoma with moderate intensity HMGA2 staining of tumor cells
Pancreas – Ductal adenocarcinoma with strong HMGA2 immunostaining of tumor cells
Pancreas – Ductal adenocarcinoma with strong HMGA2 immunostaining of tumor cells
Pancreas – HMGA2 negative adenocarcinoma of the papilla Vaterii exhibiting a moderate intensity HMGA2 staining of stroma cells
Pancreas – HMGA2 negative adenocarcinoma of the papilla Vaterii exhibiting a moderate intensity HMGA2 staining of stroma cells
Pancreas – HMGA2 negative neuroendocrine tumor
Pancreas – HMGA2 negative neuroendocrine tumor
Parathyroid – Adenoma with weak to moderate HMGA2 staining of tumor cells
Parathyroid – Adenoma with weak to moderate HMGA2 staining of tumor cells
Penis – HMGA2 negative squamous cell carcinoma
Penis – HMGA2 negative squamous cell carcinoma
Prostate – HMGA2 negative adenocarcinoma (Gleason 3+3=6)
Prostate – HMGA2 negative adenocarcinoma (Gleason 3+3=6)
Salivary gland – HMGA2 negative Warthin tumor
Salivary gland – HMGA2 negative Warthin tumor
Salivary gland – Pleomorphic adenoma with strong HMGA2 staining of tumor cells
Salivary gland – Pleomorphic adenoma with strong HMGA2 staining of tumor cells
Skin – Merkel cell carcinoma with intense HMGA2 staining of all tumor cells
Skin – Merkel cell carcinoma with intense HMGA2 staining of all tumor cells
Soft tissue – Angiosarcoma with strong HMGA2 staining of tumor cells
Soft tissue – Angiosarcoma with strong HMGA2 staining of tumor cells
Soft tissue – Chondrosarcoma with strong HMGA2 staining of tumor cells
Soft tissue – Chondrosarcoma with strong HMGA2 staining of tumor cells
Soft tissue – HMGA2 negative leiomyosarcoma
Soft tissue – HMGA2 negative leiomyosarcoma
Soft tissue – Liposarcoma with a strong HMGA2 staining of tumor cells
Soft tissue – Liposarcoma with a strong HMGA2 staining of tumor cells
Soft tissue – Liposarcoma with strong HMGA2 staining of all tumor cells
Soft tissue – Liposarcoma with strong HMGA2 staining of all tumor cells
Soft tissue – Myxofibrosarcoma showing a strong HMGA2 staining of tumor cells
Soft tissue – Myxofibrosarcoma showing a strong HMGA2 staining of tumor cells
Soft tissue – Rhabdoid tumor with strong HMGA2 positivity of tumor cells
Soft tissue – Rhabdoid tumor with strong HMGA2 positivity of tumor cells
Stomach – Gastric adenocarcinoma (intestinal type) with strong HMGA2 staining of tumor cells
Stomach – Gastric adenocarcinoma (intestinal type) with strong HMGA2 staining of tumor cells
Stomach – Gastric adenocarcinoma (intestinal type) with weak to moderate HMGA2 staining of most tumor cells
Stomach – Gastric adenocarcinoma (intestinal type) with weak to moderate HMGA2 staining of most tumor cells
Stomach – Gastrointestinal stromal tumor (GIST) showing a moderate to strong HMGA2 staining of tumor cells
Stomach – Gastrointestinal stromal tumor (GIST) showing a moderate to strong HMGA2 staining of tumor cells
Stomach – HMGA2 negative gastric adenocarcinoma (diffuse type)
Stomach – HMGA2 negative gastric adenocarcinoma (diffuse type)
Testis – HMGA2 negative Leydig cell tumor
Testis – HMGA2 negative Leydig cell tumor
Testis – HMGA2 negative seminoma
Testis – HMGA2 negative seminoma
Testis – Yolk sack tumor showing strong HMGA2 staining of tumor cells. of tumor cells
Testis – Yolk sack tumor showing strong HMGA2 staining of tumor cells. of tumor cells
Thymus – Thymoma with weak to moderate HMGA2 positivity of tumor cells
Thymus – Thymoma with weak to moderate HMGA2 positivity of tumor cells
Thyroid – Anaplastic carcinoma with strong HMGA2 positivity of tumor cells
Thyroid – Anaplastic carcinoma with strong HMGA2 positivity of tumor cells
Thyroid – Anaplastic carcinoma with strong HMGA2 staining of most tumor cells
Thyroid – Anaplastic carcinoma with strong HMGA2 staining of most tumor cells
Thyroid – Follicular carcinoma with strong HMGA2 staining of all tumor cells
Thyroid – Follicular carcinoma with strong HMGA2 staining of all tumor cells
Thyroid – Medullary carcinoma with moderate to strong HMGA2 staining of tumor cells
Thyroid – Medullary carcinoma with moderate to strong HMGA2 staining of tumor cells
Thyroid – Papillary carcinoma with strong HMGA2 staining of tumor cells
Thyroid – Papillary carcinoma with strong HMGA2 staining of tumor cells
Urinary bladder – HMGA2 negative muscle-invasive urothelial carcinoma
Urinary bladder – HMGA2 negative muscle-invasive urothelial carcinoma
Urinary bladder – Muscle-invasive urothelial carcinoma (pT2-4) with strong HMGA2 staining of tumor cells
Urinary bladder – Muscle-invasive urothelial carcinoma (pT2-4) with strong HMGA2 staining of tumor cells
Urinary bladder – Sarkomatoid carcinoma with strong HMGA2 positivity of tumor cells
Urinary bladder – Sarkomatoid carcinoma with strong HMGA2 positivity of tumor cells
Urinary bladder – Sarkomatoid carcinoma with weak to moderate HMGA2 staining of a fraction of tumor cells
Urinary bladder – Sarkomatoid carcinoma with weak to moderate HMGA2 staining of a fraction of tumor cells
Uterus, cervix – HMGA2 negative adenocarcinoma
Uterus, cervix – HMGA2 negative adenocarcinoma
Uterus, cervix – HMGA2 negative squamous cell carcinoma
Uterus, cervix – HMGA2 negative squamous cell carcinoma